Table 3 Late complications of adults who underwent Ross or mAVR |
Table 3 Late complications of adults who underwent Ross or
mAVR |
Table 3 Late complications of adults who underwent Ross
or mAVR |
Table 3 Late complications of adults who underwent
Ross or mAVR |
|
Any Complications at Follow-Up |
Any Complications at
Follow-Up |
Any Complications at Follow-Up |
|
Estimates for Ross |
95% CI |
p-value
|
Time-to-follow-up (y)a
|
-0.64 |
-3.28, 1.99 |
0.62 |
New York Heart Association functional classificationb
|
0.36 |
0.09, 1.44 |
0.15 |
Echocardiograma |
|
|
|
Left ventricular ejection fraction (%) |
4.65 |
-3.02, 12.33 |
0.24 |
Peak aortic valve gradient (mm Hg) |
-23.00 |
-33.90, -12.10 |
< 0.01 |
Mean aortic valve gradient (mm Hg) |
-12.49 |
-19.17, -5.80 |
< 0.01 |
Peak pulmonic valve gradient (mm Hg) |
2.48 |
-1.85, 6.81 |
0.26 |
Mean pulmonic valve gradient (mm Hg) |
3.29 |
-1.23, 7.80 |
0.15 |
Sinus of Valsalva (mm) |
4.31 |
-0.30, 8.93 |
0.07 |
Ascending aorta (mm) |
-3.39 |
-14.52, 7.74 |
0.55 |
Late complicationsbc |
|
|
|
Bleeding |
0.03 |
0, 0.24 |
< 0.01 |
Stroke |
0.06 |
0.00, 0.51 |
< 0.01 |
Endocarditis |
0.17 |
0, 1.66 |
0.13 |
Arrhythmia |
1.63 |
0.34, 9.01 |
0.73 |
Aortic root dilatation |
4.10 |
0.99, 18.96 |
0.052 |
Ascending aortic dilatation |
6.37 |
0.70, 315.12 |
0.13 |
Among patients who had any complication at follow-up, variables
expressed above as amatched 𝛽-coefficients or
bmatched odds ratio. cexact weight
logistical regression. |
Among patients who had any complication at
follow-up, variables expressed above as amatched
𝛽-coefficients or bmatched odds ratio.
cexact weight logistical regression. |
Among patients
who had any complication at follow-up, variables expressed above as
amatched 𝛽-coefficients or bmatched
odds ratio. cexact weight logistical regression. |
Among patients who had any complication at follow-up, variables
expressed above as amatched 𝛽-coefficients or
bmatched odds ratio. cexact weight
logistical regression. |